发明名称 |
Method of preventing adverse effects by GLP-1 |
摘要 |
A method for preventing or reducing adverse effects such as profuse sweating, nausea and vomiting, which normally are associated with subcutaneous and intravenous administration of glucagon-like peptide 1 (GLP-1 ) therapy is provided. In particular, the method comprises the rapid administration of a GLP-1 formulation into the pulmonary circulation such as by inhalation, directly into pulmonary alveolar capillaries using a dry powder drug delivery system. |
申请公布号 |
AU2008316634(B2) |
申请公布日期 |
2014.02.27 |
申请号 |
AU20080316634 |
申请日期 |
2008.10.24 |
申请人 |
MANNKIND CORPORATION |
发明人 |
BAUGHMAN, ROBERT A.;RICHARDSON, PETER;COSTELLO, DONALD |
分类号 |
A61K9/14;A61K31/495;A61K38/26 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|